vimarsana.com
Home
Live Updates
AXS-12 Reduces Narcolepsy Symptoms in Phase 3 Trial : vimars
AXS-12 Reduces Narcolepsy Symptoms in Phase 3 Trial : vimars
AXS-12 Reduces Narcolepsy Symptoms in Phase 3 Trial
Axsome Therapeutics announced topline trial results, which show AXS-12 significantly improves key narcolepsy symptoms.
Related Keywords
,
Michael Thorpy ,
Herriot Tabuteau ,
Albert Einstein College Of Medicine ,
Montefiore Medical Center ,
Wake Disorders Center ,
Axsome Therapeutics ,
Axsome Therapeutic ,
Clinician Global Impression ,
Narcolepsy Symptom Assessment ,
Epworth Sleepiness Scale ,
Cognitive Function Items ,
Functional Outcomes ,
Sleep Questionnaire ,
Sleep Wake Disorders Center ,
Albert Einstein College ,